Healthcare -
Biotechnology - NASDAQ - US
$ 25.535
2.55 %
$ 279 M
Market Cap
-1.07
P/E
CDTX - OPERATING INCOME
Operating Income CDTX - Cidara Therapeutics, Inc.
-24.5 M
LAST VALUE
23.88%
2 YEAR CAGR
17.30%
5 YEAR CAGR
-36.60%
10 YEAR CAGR